Medical risk in patients with bipolar disorder and schizophrenia

被引:155
|
作者
Newcomer, John W.
机构
[1] Washington Univ, Sch Med, Dept Psychiat Psychol & Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
D O I
10.4088/JCP.1106e16
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Patients with schizophrenia and bipolar disorder are vulnerable to developing key modifiable risk factors for cardiovascular disease, such as obesity, smoking, hypertension, dyslipidemia, and type 2 diabetes mellitus. In addition, mood stabilizers, anticonvulsants, and antipsychotic medications, which are commonly used to treat schizophrenia and bipolar disorder, have been linked to risk for adverse metabolic changes in patients. This article reviews the current literature on the prevalence of medical risk factors in the general population as well as in those patients with schizophrenia or bipolar disorder and discusses treatment strategies and lifestyle changes that patients can make in order to reduce their risks for certain diseases.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [21] Risk counselling for family members in bipolar disorder and schizophrenia
    Gershon, Elliot S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (03): : 713 - 714
  • [22] Comparison of older patients with bipolar disorder and schizophrenia/schizoaffective disorder
    Gupta, Sanjay
    Steinmeyer, Charles H.
    Lockwood, Kari
    Lentz, Barbara
    Schultz, Kay
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (07): : 627 - 633
  • [23] Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia
    Johannessen, Line
    Strudsholm, Ulla
    Foldager, Leslie
    Munk-Jorgensen, Povl
    JOURNAL OF AFFECTIVE DISORDERS, 2006, 95 (1-3) : 13 - 17
  • [24] Schizophrenia and bipolar disorder
    Olivier, D
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (03): : 387 - 387
  • [25] Risk of malignancy in patients with schizophrenia or bipolar disorder - Nested case-control study
    Hippisley-Cox, Julia
    Vinogradova, Yana
    Coupland, Carol
    Parker, Chris
    ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (12) : 1368 - 1376
  • [26] The Risk of Myocarditis, Cardiomyopathy and Cutaneous Vasculitis Associated with Quetiapine in Patients With Schizophrenia and Bipolar Disorder
    Lee, Yeji
    Jang, Bowon
    Kim, Bonggi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 293 - 294
  • [27] Risk of Schizophrenia and Bipolar Disorder in Patients With Multiple Sclerosis: Record-Linkage Studies
    Meier, Ute-Christiane
    Ramagopalan, Sreeram, V
    Goldacre, Michael J.
    Goldacre, Raph
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [28] CELL TYPE-SPECIFIC POLYGENIC RISK PROFILING IN SCHIZOPHRENIA AND BIPOLAR DISORDER PATIENTS
    Papiol, Sergi
    Kannaiyan, Nirmal Raman
    Anderson-Schmidt, Heike
    Budde, Monika
    Gade, Katrin
    Heilbronner, Urs
    Falkai, Peter
    Rossner, Moritz J.
    Schulze, Thomas G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S330 - S330
  • [29] THE IMPACT OF BIPOLAR AND SCHIZOPHRENIA POLYGENIC RISK SCORES ON FAMILIAL FEATURES OF BIPOLAR DISORDER
    Gade, Katrin
    Papiol, Sergi
    Heilbronner, Urs
    Budde, Monika
    Adorjan, Kristina
    Anderson-Schmidt, Heike
    Kalman, Janos
    Aldinger, Fanny
    Andlauer, Till F. M.
    Schulze, Thomas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S968 - S968
  • [30] EFFECTS OF SCHIZOPHRENIA AND BIPOLAR POLYGENIC RISK SCORES ON AGE AT ONSET IN BIPOLAR DISORDER
    Kalman, Janos
    Papiol, Sergi
    Heilbronner, Urs
    Andlauer, Till F. M.
    Anderson-Schmidt, Heike
    Budde, Monika
    Gade, Katrin
    Herms, Stefan
    Forstner, Andreas J.
    Frank, Josef
    Degenhardt, Franziska
    Noethen, Markus
    Rietschel, Marcella
    Falkai, Peter
    Schulze, Thomas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S967 - S967